Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What’s the Current Status?

Targeted Oncology 2026

View at publisher
Authors: Finn Segers, Michel Delforge
DOI: 10.1007/s11523-025-01189-7
Cited by: 2
References: 250

Fields of Study & Subjects

CAR-T cell therapy research Multiple Myeloma Research and Treatments Monoclonal and Polyclonal Antibodies Research

Publication details

Journal / source
Targeted Oncology
Publisher
Springer Science and Business Media LLC
Volume
21
Issue
1
Pages
63–86
Publication date
1 January 2026
Language
EN